Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 16, 2023; 11(5): 1165-1174
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1165
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1165
Figure 1 Pelvic magnetic resonance imaging during different treatment stages.
A: Tumor site before treatment; B: Lymph node before treatment; C: Tumor site after 2 cycles of treatment; D: Lymph node after 2 cycles of treatment; E: Tumor site after 4 cycles of treatment; F: lymph node after 4 cycles of treatment; G: Tumor site after 2 yr of treatment; H: Lymph node after 2 yr of treatment.
- Citation: Yang R, Chen JX, Luo SH, Chen TT, Chen LW, Huang B. Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report. World J Clin Cases 2023; 11(5): 1165-1174
- URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1165.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i5.1165